David M. Knott Jr’s Verona Pharma VRNA Stock Holding History

David M. Knott Jr’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-38,355	Closed	-$4.09M	–	98
2025 Q3	$4.09M	Sell	38,355 -16,645	-30%	-$1.74M	1.65%	14
2025 Q2	$5.2M	Sell	55,000 -33,000	-38%	-$2.44M	2.36%	6
2025 Q1	$5.59M	Sell	88,000 -71,300	-45%	-$4.26M	2.64%	8
2024 Q4	$7.4M	Sell	159,300 -20,700	-12%	-$777K	2.68%	7
2024 Q3	$5.18M	Sell	180,000 -23,000	-11%	-$566K	1.82%	11
2024 Q2	$2.94M	Buy	203,000 +88,000	+77%	+$1.28M	1.17%	16
2024 Q1	$1.85M	Buy	115,000 +82,328	+252%	+$1.42M	0.65%	30
2023 Q4	$650K	Buy	+32,672	New	+$482K	0.25%	39

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

David M. Knott Jr's VRNA Position: Q4 2025 in Review

David M. Knott Jr sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 38,355 shares — an estimated $4.09M sold.

David M. Knott Jr first reported a position in VRNA in Q4 2023 and held it in 8 quarters. The position peaked at $7.4M in Q4 2024. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

David M. Knott Jr reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
David M. Knott Jr sold 38,355 Verona Pharma shares in Q4 2025, an estimated $4.09M.
David M. Knott Jr first reported a position in Verona Pharma in Q4 2023 and held it in 8 quarters.
David M. Knott Jr's Verona Pharma position peaked at $7.4M in Q4 2024.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on David M. Knott Jr's 13F filing for Q4 2025, filed 12 Feb 2026.